Invesaro

Stocks AMAT Financial statements

Financial statements

APPLIED MATERIALS INC /DE financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data APPLIED MATERIALS INC /DE files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue10,82514,69816,70514,60817,20223,06325,78526,51727,17628,368
Cost of revenue6,3148,0869,1888,2229,51012,14913,79214,13314,27914,560
Gross profit4,5116,6127,5176,3867,69210,91411,99312,38412,89713,808
Research and development1,5401,7812,0222,0542,2342,4852,7713,1023,2333,570
Selling, general and administrative1,6281,7971,768
Selling and marketing429457521521526609703776836858
General and administrative390438483461567620735852961910
Operating expenses2,3592,6763,0263,0363,3274,0254,2054,7305,0305,519
Operating income2,1523,9364,4913,3504,3656,8897,7887,6547,8678,289
Interest expense155198234237240236228238247269
Interest income262486406
Other non-operating income167813915641118393005321,251
Pre-tax income2,0133,8164,3963,2694,1666,7717,5997,7168,1529,271
Income tax2922971,3585635478831,0748609752,273
Net income1,7213,5193,0382,7063,6195,8886,5256,8567,1776,998
EBITDA2,5414,3434,9483,7134,7417,2838,2328,1698,2598,724
EPS, basic1.563.283.002.893.956.477.498.168.688.71
EPS, diluted1.543.252.962.863.926.407.448.118.618.66
Shares, basic (weighted)1,1071,0731,013937916910871840827804
Shares, diluted (weighted)1,1161,0841,026945923919877845834808
Dividend per share0.100.100.700.830.870.941.021.221.521.78

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents3,4065,0103,4403,1295,3514,9951,9956,1328,0227,241
Short-term investments3432,2665904893874645867371,4491,332
Receivables2,2792,3382,3232,5332,9634,9536,0685,1655,2345,185
Inventory2,0502,7073,7213,4743,9044,3095,9325,7255,4215,915
Other current assets2753745305817641,3861,3441,3881,0941,208
Total current assets8,35312,91810,60410,20613,36916,10715,92519,14721,22020,881
Property, plant and equipment9371,0661,4071,5291,6041,9342,3072,7233,3394,610
Lease right-of-use assets0252294389370375509
Goodwill3,3163,3683,3683,3993,4663,4793,7003,7323,7323,707
Intangible assets575412213156153104339294249226
Long-term investments9291,1431,5681,7031,5382,0551,9802,2812,7874,327
Other non-current assets248265260229691345314806
Total assets14,57019,41917,63319,02422,35325,82526,72630,72934,40936,299
Accounts payable8139459969581,1241,4721,7551,4781,5701,978
Accrued liabilities5176666395598009249051,0241,1881,221
Deferred revenue9051,2841,2011,3361,3212,0763,1422,9752,8492,566
Short-term debt200006000007000
Total current liabilities3,6324,1153,9224,4474,4596,3447,3797,3728,4687,999
Long-term debt3,1255,3045,3094,7135,4485,4525,4575,4615,4606,455
Lease liabilities0195228287252259404
Other non-current liabilities77991261636626927327148101,074
Total liabilities7,35310,07010,78810,81011,77513,57814,53214,38015,40815,884
Total debt3,1255,3045,3095,3135,4485,4525,4575,4616,1606,455
Paid-in capital6,8097,0567,2747,5957,9048,2478,5939,1319,66010,333
Retained earnings15,25218,25820,88024,38627,20932,24637,89243,72649,65155,227
Treasury stock-14,740-15,912-21,194-23,596-24,245-27,995-34,097-36,299-40,150-45,043
Other comprehensive income-115-64-125-180-299-260-202-217-168-110
Shareholders' equity7,4139,6306,8458,21410,57812,24712,19416,34919,00120,415
Total equity7,4139,6306,8458,21410,57812,24712,19416,34919,00120,415
Total liabilities and equity14,57019,41917,63319,02422,35325,82526,72630,72934,40936,299
Shares outstanding1,0781,060967916914892844833818793

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income1,7213,5193,0382,7063,6195,8886,5256,8567,1776,998
Depreciation and amortization389407457363376394444515392435
Stock-based compensation201220258263307346413490577668
Deferred income tax-21-12198516860195-358-6781,153
Change in receivables-542-3716-207-427-1,989-1,109903-6949
Change in inventory-216-809-1,014248-421-405-1,590207304-494
Change in payables184371170-247327465390-138281307
Cash from operations2,5663,7893,7873,2473,8045,4425,3998,7008,6777,958
Capital expenditures-253-345-622-441-422-668-787-1,106-1,190-2,260
Acquisitions-16-68-6-28-107-12-441-250-29
Purchases of investments-1,390-4,856-2,077-1,914-1,355-2,007-1,492-1,672-3,588-6,054
Sales and maturities of investments1,2342,7433,2761,9401,7541,4711,363
Cash from investing-425-2,526571-443-130-1,216-1,357-1,535-2,327-2,782
Debt issued02,176002,979000694991
Debt repaid-1,207-20500-2,8820000-700
Stock issued8897124145174175199227243261
Share buybacks-1,892-1,172-5,283-2,403-649-3,750-6,103-2,189-3,823-4,895
Dividends paid-444-430-605-771-787-838-873-975-1,192-1,384
Cash from financing-3,532341-5,928-3,115-1,337-4,591-7,043-3,032-4,470-5,977
Net change in cash-1,3911,604-1,570-3112,337-365-3,0014,1331,880-801
Free cash flow2,3133,4443,1652,8063,3824,7744,6127,5947,4875,698
Interest paid151186219219219205205205205239
Income taxes paid1571943005225428511,8691,0069571,504

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 26, 2026; growth uses fiscal years. Valuation uses the share price of $485.00 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin49.4%Gross profit / revenue.
Operating margin29.6%Operating income / revenue.
EBITDA margin31.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin34.8%Pre-tax income / revenue.
Net margin30.1%Net income / revenue.
FCF margin18.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin27.2%Cash from operations / revenue.
Effective tax rate13.6%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)36.2%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)21.3%Net income / average total assets.
Return on invested capital (ROIC)31.5%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue12.9%Research and development expense / revenue.
SG&A / revenue5.4%Selling, general and administrative expense / revenue.
Stock-based pay / revenue2.3%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue9.0%Capital expenditures / revenue.
D&A / revenue1.7%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y4.4%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.2%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y10.5%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y7.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.8%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y12.4%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y5.4%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y2.1%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y13.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y5.6%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y2.0%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y13.0%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y-2.5%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y2.4%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y14.1%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y0.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y5.2%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y17.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-8.3%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y13.8%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y15.9%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-23.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y7.3%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y11.0%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y17.1%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y20.4%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y15.4%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y7.4%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y18.7%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y14.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y5.5%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y10.7%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y10.2%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-3.1%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-2.7%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-2.6%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio2.42xCurrent assets / current liabilities.
Quick ratio1.63x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.89x(Cash + short-term investments) / current liabilities.
Debt / equity0.25xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets14.8%Total debt / total assets.
Liabilities / assets41.1%Total liabilities / total assets.
Net debt-$2.79BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA-0.29xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage33.0xOperating income / interest expense.
Working capital$14.74BCurrent assets - current liabilities.
Goodwill and intangibles / assets9.6%(Goodwill + intangible assets) / total assets.
Tangible book value$21.44BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.71xRevenue / average total assets.
Fixed asset turnover5.50xRevenue / average property, plant and equipment.
Inventory turnover2.38xCost of revenue / average inventory.
Days inventory154 days365 x average inventory / cost of revenue.
Receivables turnover4.01xRevenue / average receivables.
Days sales outstanding91 days365 x average receivables / revenue.
Days payables56 days365 x average accounts payable / cost of revenue.
Cash conversion cycle189 daysDays inventory + days sales outstanding - days payables.
FCF conversion60.7%Free cash flow / net income, when net income is positive.
Capex / operating cash flow33.0%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$11.58Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$38.55Revenue / diluted weighted shares.
FCF per share$7.03Free cash flow / diluted weighted shares.
Operating cash flow per share$10.50Cash from operations / diluted weighted shares.
Book value per share$32.03Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$26.80Tangible book value / shares outstanding.
Cash per share$11.54(Cash + short-term investments) / shares outstanding.
Payout ratio16.3%Dividends paid / net income, when net income is positive.
Dividends / FCF26.9%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF36.1%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$385.07BShare price x shares outstanding.
Enterprise value$382.28BMarket cap + total debt - cash - short-term investments.
P/E41.6xMarket cap / net income. Only when net income is positive.
P/S12.5xMarket cap / revenue.
P/B15.0xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book18.0xMarket cap / tangible book value, when positive.
P/FCF68.5xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF45.9xMarket cap / cash from operations, when positive.
EV/Sales12.4xEnterprise value / revenue.
EV/EBIT41.8xEnterprise value / operating income, when both are positive.
EV/EBITDA39.5xEnterprise value / EBITDA, when both are positive.
EV/FCF68.0xEnterprise value / free cash flow, when both are positive.
FCF yield1.5%Free cash flow / market cap.
Earnings yield2.4%Net income / market cap (the inverse of P/E).
Dividend yield0.4%Dividends paid over the period / market cap.
Shareholder yield0.9%(Dividends paid + share buybacks) / market cap.
PEG8.00xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was APPLIED MATERIALS INC /DE's revenue in fiscal 2025?

APPLIED MATERIALS INC /DE reported revenue of $28.37B for fiscal 2025, 4.4% higher than the year before.

Was APPLIED MATERIALS INC /DE profitable in fiscal 2025?

Yes. Net income was $7.00B, a net margin of 24.7%.

How much free cash flow did APPLIED MATERIALS INC /DE generate in fiscal 2025?

Cash from operations of $7.96B minus capital expenditures of $2.26B left free cash flow of $5.70B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to APPLIED MATERIALS INC /DE